Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Full Text
See detailPathways of Human T-Lymphotropic Virus type I for viral entry
Boulanger, F.; Rodriguez, Sabrina ULg; Willems, L.

Scientific conference (2011, June 06)

Pathways of Human T-Lymphotropic Virus type I for viral entry Boulanger Fanny N.J., Rodriguez Sabrina and Willems Luc Cellular and Molecular Epigenetics, GIGA-Research, Liège The Human T-Lymphotropic ... [more ▼]

Pathways of Human T-Lymphotropic Virus type I for viral entry Boulanger Fanny N.J., Rodriguez Sabrina and Willems Luc Cellular and Molecular Epigenetics, GIGA-Research, Liège The Human T-Lymphotropic Virus type I (HTLV-1), the first discovered human retrovirus, infects an estimated number of 20 million people worldwide. HTLV-1 is the causative agent of Adult T-cell Leukemia/Lymphoma (ATL) and a neurodegenerative disease called HTLV associated myeolopathy / tropical spastic paraparesis (HAM/TSP). We have been interested in the early steps of HTLV entry into cells. Infection requires interaction of the viral envelope glycoproteins (SU and TM) with the cell membrane. Three molecules are required for binding and entry into cells: heparan-sulfate proteoglycans (HSPGs), the VEGF-165 receptor Neuropilin 1 (NRP-1) and the ubiquitous glucose transporter GLUT-1. Consecutive steps of HTLV-1 entry are poorly characterized. These could involve phagocytosis/macropinocytosis, caveolae pathway, clathrin-mediated endocytosis, and several mechanisms independent of these two organelles but mediated by dynamin. To identify the endocytic pathways of HTLV-1 entry, we used two complementary strategies based either on pharmacological inhibition or on dominant-negative proteins expression. First, we evaluated the effect of a series of pharmacological inhibitors to interfere with main endocytic pathways. We used wortmannin and cytochalasin D to interfere with phagocytosis and macropinocytosis through their action on phosphatidyl-inositol-3 kinase and on the actin network, respectively. Clathrin-mediated endocytosis was blocked with chlorpromazine and with a polyclonal anti-clathrin antibody as a direct competitor for the formation of clathrin-coated pits. The caveolar function was disrupted with the sterol-binding drug nystatin and the protein tyrosine-kinase inhibitor genistein. Finally, dynamin was competed with a peptide (Dynamin Inhibitory Peptide) or inhibited by dynasore. Since pharmacological inhibitors may have off-target effects, we also used an alternate approach based on dominant-negative proteins expressed by lentivirus-derived vectors. An AP-2-binding site from Eps15 (Epidermal Growth Factor Receptor Substrate 15) was used to interfere with clathrin-mediated endocytosis. A N-terminally GFP-tagged caveolin-1 construct acted as an inhibitor of the caveolae pathway. A dominant-negative GTP-binding mutant of dynamin2(aa) was used to interfere with dynamin-dependant internalization pathways. Lentiviruses expressing these dominant-negative proteins were transduced into several cell lines or primary cells (T-lymphocytes and dendritic cells). These transduced cells were then infected by co-cultivation with HTLV-1-infected T-lymphocytes (MT2) or with free particles. These different approaches will thus allow identifying the pathways involved in cell entry by HTLV-1. [less ▲]

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailPatient assessment using standardized bone mineral density values and a national reference database: implementing uniform thresholds for the reimbursement of osteoporosis treatments in Belgium
Boonen, S.; Kaufman, J. M.; Reginster, Jean-Yves ULg et al

in Osteoporosis International (2003), 14(2), 110-115

Dual-energy X-ray absorptiometry (DXA) devices from the three main manufacturers provide different bone mineral density (BMD) values, due in part to technical differences in the algorithms for bone ... [more ▼]

Dual-energy X-ray absorptiometry (DXA) devices from the three main manufacturers provide different bone mineral density (BMD) values, due in part to technical differences in the algorithms for bone mineral content (BMC) and area measurements and in part to the use of different manufacturer-derived reference databases. As a result, significant differences exist between Hologic, Lunar and Norland systems in the reported young normal standard deviation scores or T-scores. In a number of European countries, including Belgium, a T-score below -2.5 is one of the key criteria for reimbursement of osteoporosis treatments. This paper addresses the first attempt to implement a nationwide, uniform expression of BMD in patients, in order to harmonize drug reimbursement. To this end, measures were taken to implement a uniform expression of BMD in Belgian patients, by converting each manufacturer's absolute BMD to standardized BMD (sBMD) values and by establishing a single national reference range. [less ▲]

Detailed reference viewed: 29 (0 ULg)
Full Text
Peer Reviewed
See detailLe patient cancéreux ambulatoire traité par radiothérapie
Vanderick, JEAN ULg

in Revue Médicale de Bruxelles (1998), 18(4), 221-225

Le peu de connaissances en radiothérapie acquises par le médecin généraliste au cours de sa formation le rendent souvent désarmé face à un patient qui lui pose de nombreuses questions quant aux effets ... [more ▼]

Le peu de connaissances en radiothérapie acquises par le médecin généraliste au cours de sa formation le rendent souvent désarmé face à un patient qui lui pose de nombreuses questions quant aux effets secondaires du traitement ou le consulte en urgence suite à la survenue brutale de réactions imprévues. Quelle attitude adopter face à une dermite, une mucite, une leucopénie, une alopécie, sur radiothérapie ? Sans se montrer exhaustif, cet article vise à expliquer la pathogénie des réactions aiguës ou chroniques les plus fréquentes rencontrées lors des traitements ambulatoires, à aider à leur reconnaissance précoce, à envisager leur suivi en commun avec le radiothérapeute, leur pronostic et si nécessaire leur traitement en première ligne. [less ▲]

Detailed reference viewed: 138 (1 ULg)
Full Text
Peer Reviewed
See detailPatient coronarien avec co-morbidites: integrer indications et contre-indications dans le raisonnement pharmaco-therapeutique.
Scheen, André ULg

in Revue Médicale de Liège (2010), 65(7-8), 476-81

A patient with abdominal obesity, type 2 diabetes, arterial hypertension and dyslipidaemia is exposed to a high risk of coronary artery disease, congestive heart failure and/or renal insufficiency. The ... [more ▼]

A patient with abdominal obesity, type 2 diabetes, arterial hypertension and dyslipidaemia is exposed to a high risk of coronary artery disease, congestive heart failure and/or renal insufficiency. The management of such a patient requires different medications, which should be prescribed by taking into account both (relative and absolute) indications and contra-indications to improve overall prognosis. The present clinical case report illustrates the therapeutic reasoning leading to an appropriate pharmacological polytherapy, combined with life-style changes. [less ▲]

Detailed reference viewed: 44 (0 ULg)
Peer Reviewed
See detailPatient morbidity after 2 different surgical protocols to treat miller class I recession in the anterior maxilla: A Comparaitive Ramdomized Control Trial.
SALHI, Leila ULg; ROMPEN, Eric ULg; LECLOUX, Geoffrey ULg et al

Conference (2012, June)

Aim: The objective of this study was to compare two different periodontal plastic surgery procedures to treat Miller’s class I recession: a coronally advanced flap (control group) versus the pouch ... [more ▼]

Aim: The objective of this study was to compare two different periodontal plastic surgery procedures to treat Miller’s class I recession: a coronally advanced flap (control group) versus the pouch technique (test group), both of which were associated with connective tissue graft. Methods: Forty consecutive patients were included, with 20 patients being allocated for each group. The level of recession coverage, the keratinised tissue quantity, gingival aesthetics (PES), and postoperative outcomes were assessed for a follow-up period of 6 months. Results: After 6 months, both techniques allowed for the excellent mean root coverage of 96.3 ± 12.1% in the control group and of 91.3 ± 17.6% in the test group. Complete root coverage was achieved in 89.5% (17/19) and 79% (15/19) of the recession cases in the control and the test groups, respectively. A significant increase in keratinised tissue height (p=0.0011) was observed in the test group. A significant improvement in the pink aesthetic score was found in the 2 groups, but gingival texture displayed significantly better results in the test group (p<0.0001). No significant difference between the 2 groups was found in terms of the morbidity outcomes. Pain killer consumption was similar in the 2 groups and significantly decreased over time. [less ▲]

Detailed reference viewed: 18 (4 ULg)
Peer Reviewed
See detailPatient morbidity after socket preservation using a connective tissue graft versus a bilayer collagen matrix: Preliminary results of a comparative Randomized Control Trial.
FERNANDEZ AYORA, Alberto ULg; VANHOUTTE, Vanessa ULg; LECLOUX, Geoffrey ULg et al

Poster (2012, June)

INTRODUCTION AND AIM: The present randomized controlled trial compared socket preservation procedures using bovine hydroxyapatite (Bio-Oss®, Geistlich, Switzerland) covered with a connective tissue graft ... [more ▼]

INTRODUCTION AND AIM: The present randomized controlled trial compared socket preservation procedures using bovine hydroxyapatite (Bio-Oss®, Geistlich, Switzerland) covered with a connective tissue graft (CT) versus a bilayer collagen membrane (CM) (Mucograft®, Geistlich, Switzerland), placed from buccal to palatal in split-thickness pouches in order to seal the extraction site and to potentially thicken the buccal mucosa. The aim of this present abstract was to evaluate post-operative complications and patient-centered outcomes of the two independent surgical protocols. METHODS: This randomized controlled trial included 26 patients (16 female, 10 male) aged from 20 to 69 years (mean: 42.6, SD: 12). 26 teeth were extracted atraumatically and the 2 distinct surgical protocols were applied randomly. Patients filled out a VAS form 1 week after the surgery to evaluate their level of discomfort and post-operative pain. Drug intakes as well as complications were also recorded. RESULTS: No statistical significant differences were found between the 2 groups in terms of post-operative complications (bleeding) and post-operative pain. The consumption of painkillers after the surgery decreased over time but was similar in the two groups. CONCLUSION: According to the preliminary results of the present RCT, none of both protocols seemed to induce significant post-operative pain and discomfort. There was no difference between the two procedures regarding post-operative complications and patient centered outcomes. [less ▲]

Detailed reference viewed: 43 (3 ULg)
Full Text
Peer Reviewed
See detailPatient out-of-pocket contributions related to hip fracture hospital costs in Belgium
Hiligsmann, Mickaël ULg; Gathon, Henry-Jean ULg; Bruyère, Olivier ULg et al

in Osteoporosis International (2011, March), 22(Suppl.1), 333

Detailed reference viewed: 46 (23 ULg)
Peer Reviewed
See detailLe patient polyvasculaire. Etude rétrospective de 4200 patients vasculaires opérés entre 1980 et 1986
Van Damme, Hendrik ULg; Creemers, Etienne ULg; Dekoster, Guy ULg et al

in Acta Chirurgica Belgica (1988), 88(2, Mar-Apr), 111-9

Polyvascular patients. Among a consecutive series of 4200 patients submitted to vascular surgery, a group of 292 people operated on, in at least two anatomically and physiologically different sites, is ... [more ▼]

Polyvascular patients. Among a consecutive series of 4200 patients submitted to vascular surgery, a group of 292 people operated on, in at least two anatomically and physiologically different sites, is individualized as polyvascular patients. A subgroup is characterized by simultaneous procedures in two separated fields; 32 have benefited in the same time from carotid and coronary procedures, i.e., 0.6% of all coronary patients and 2% of all carotid patients. The carotid-coronary group exhibited a more severe anatomical disease both in the carotid and the coronary vasculatures. Apart from simultaneously operated patients, others were sequentially treated over a 7 years period: people with carotid (25%) or visceral (40%) arterial disease were more prone to become polyvascular. Polyvascular patients differ from monovascular patients in that hypertension is more frequent and more severe, mean cholesterol level higher and incidence of severe hypercholesterolemia more frequent. [less ▲]

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailPatient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan
Schoenen, Jean ULg; Pascual, J.; Rasmussen, S. et al

in European Journal of Neurology (2005), 12(2), 108-117

This current randomized, open-label, crossover study evaluated preference for oral eletriptan 80 mg compared with subcutaneous sumatriptan 6 mg (suma-sc) amongst patients (n = 311) meeting IHS criteria ... [more ▼]

This current randomized, open-label, crossover study evaluated preference for oral eletriptan 80 mg compared with subcutaneous sumatriptan 6 mg (suma-sc) amongst patients (n = 311) meeting IHS criteria for migraine who had recently used suma-sc, and found it well tolerated. Three attacks were treated on each study medication. Assessment of subjective preference was evaluated, after which patients freely chose which study medication they wished to use to treat each of three additional migraine attacks. A slight majority (50.6%) preferred or greatly preferred eletriptan, whilst 43% preferred suma-sc. When permitted to choose between eletriptan and suma-sc for subsequent treatment, 78% of patients who had preferred eletriptan took eletriptan during the extension phase for all three of their attacks, whilst only 37% of patients who preferred suma-sc took suma-sc for all of their extension-phase attacks (P < 0.05). Secondary efficacy measures showed comparable efficacy for each study medication, except for faster headache response and pain-free rates favor of suma-sc, and a significantly lower recurrence rate on eletriptan (25% vs. 40%; P < 0.05). The results of this study suggest that eletriptan is a strong alternative option for patients who have been prescribed suma-sc. [less ▲]

Detailed reference viewed: 22 (0 ULg)
Full Text
Peer Reviewed
See detailPatient Preference in the Management of Postmenopausal Osteoporosis with Bisphosphonates
Reginster, Jean-Yves ULg; Rabenda, Véronique ULg

in Clinical Interventions in Aging (2006), 1(4), 415-23

The leading treatments for postmenopausal osteoporosis are the nitrogen-containing bisphosphonates, which are required long term for optimal benefit. Oral bisphosphonates have proven efficacy in ... [more ▼]

The leading treatments for postmenopausal osteoporosis are the nitrogen-containing bisphosphonates, which are required long term for optimal benefit. Oral bisphosphonates have proven efficacy in postmenopausal osteoporosis in clinical trials, but in practice the therapeutic benefits are often compromised by patients' low adherence. Nonadherence to bisphosphonate therapy negatively impacts outcomes such as fracture rate; fractures are in turn associated with decreased quality of life. The most common reason cited by patients for their nonadherence is that the strict dosing instructions for bisphosphonates are difficult to follow. One aspect of bisphosphonate administration that can be changed is dosing frequency and several studies have evaluated patient preferences for different dosing schedules. Studies have shown a preference for a weekly bisphosphonate regimen versus daily dosing and it has been demonstrated that this preference for reduced dosing frequency impacts on adherence. Ibandronate is the first nitrogen-containing oral bisphosphonate for osteoporosis that can be administered in a monthly regimen and two robust clinical studies demonstrated a strong patient preference for this monthly regimen versus a weekly regimen. It is important that physicians consider patient preference when prescribing treatment for osteoporosis to ensure that the disease is effectively managed for the long-term benefit of the patient. [less ▲]

Detailed reference viewed: 28 (2 ULg)
Peer Reviewed
See detailPatient Safety Course : Morbidity and Mortality Meeting
Nyssen, Anne-Sophie ULg

Conference (2008, May)

Detailed reference viewed: 13 (1 ULg)
Full Text
See detailPatient safety indicators
Jacques, Jessica ULg; Gillet, Pierre ULg

Report (2007)

Detailed reference viewed: 45 (9 ULg)
Full Text
Peer Reviewed
See detailPatient specific identification of the cardiac driver function in a cardiovascular system model.
Hann, C. E.; Revie, J.; Stevenson, D. et al

in Computer Methods & Programs in Biomedicine (2011)

The cardiac muscle activation or driver function, is a major determinant of cardiovascular dynamics, and is often approximated by the ratio of the left ventricle pressure to the left ventricle volume. In ... [more ▼]

The cardiac muscle activation or driver function, is a major determinant of cardiovascular dynamics, and is often approximated by the ratio of the left ventricle pressure to the left ventricle volume. In an intensive care unit, the left ventricle pressure is usually never measured, and the left ventricle volume is only measured occasionally by echocardiography, so is not available real-time. This paper develops a method for identifying the driver function based on correlates with geometrical features in the aortic pressure waveform. The method is included in an overall cardiovascular modelling approach, and is clinically validated on a porcine model of pulmonary embolism. For validation a comparison is done between the optimized parameters for a baseline model, which uses the direct measurements of the left ventricle pressure and volume, and the optimized parameters from the approximated driver function. The parameters do not significantly change between the two approaches thus showing that the patient specific approach to identifying the driver function is valid, and has potential clinically. [less ▲]

Detailed reference viewed: 12 (2 ULg)
Peer Reviewed
See detailPatient specific model of the cardiovascular system during septic shock
Desaive, Thomas ULg; Chase, J. G.; Lambermont, Bernard ULg et al

in Intensive Care Medicine (2009), 35(suppl. 1), 80

Detailed reference viewed: 55 (12 ULg)
Full Text
Peer Reviewed
See detailPatient specific modelling of cardiac muscle activation
Stevenson, D; Hann, CE; Revie, JA et al

in Proceedings of the Health Research Society of Canterbury (HRSC) Clinical Meeting 2010 (2010)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailA patient who survived total colonic ulcerative colitis surinfected by cytomegalovirus complicated by toxic megacolon and disseminated intravascular coagulation
Laurent, S.; Reenaers, Catherine ULg; Detroz, Bernard ULg et al

in Acta Gastro-Enterologica Belgica (2005), 68(2, Apr-Jun), 276-279

The authors report the case of a patient aged 60-year-old who survived ulcerative colitis complicated by toxic megacolon and disseminated intravascular coagulation. This patient was not known for this ... [more ▼]

The authors report the case of a patient aged 60-year-old who survived ulcerative colitis complicated by toxic megacolon and disseminated intravascular coagulation. This patient was not known for this ulcerative colitis and was first hospitalised for a suspicion of diverticulitis. The admission symptoms were fever, abdominal pain and bloody diarrhoea. The evolution was defavorable under antibiotics and sulfasalazine. The patient was readmitted 5 days after he left hospital, and the diagnosis of UC was based on colon biopsy made during the first hospitalisation. A treatment with methylprednisolone was started and the patient worsened day by day with apparition of toxic megacolon and disseminated intravascular coagulation. Subtotal colectomy was performed for degradation of general status and coagulation factors. Pathological findings confirmed ulcerative colitis with toxic megacolon. Cytomegalovirus inclusions were demonstrated on the colonic specimen and confirmed by PCR. In this report the authors discuss the etiology of toxic megacolon and disseminated intravascular coagulation in ulcerative colitis surinfected by cytomegalovirus. Mortality of these pathologies is high necessitating rapid diagnosis of cytomegalovirus infection by sigmoid biopsy. Management requires immunosupression interruption and ganciclovir therapy, or surgery in unsuccessful medical treatment. [less ▲]

Detailed reference viewed: 50 (5 ULg)
Full Text
Peer Reviewed
See detailA Patient with Hiv Infection, Cough, Asthenia, and Fever
Mayasi, N.; Chandrikakumari, Kavitha; Mukeba, D. et al

in Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America (2007), 45(5), 662-3559-600

Detailed reference viewed: 20 (10 ULg)
Full Text
Peer Reviewed
See detailLe patient, sa famille et l'équipe thérapeutique de l'hôpital de jour: à la recherche d'une alliance
Triffaux, Jean-Marc ULg

in Gonsalves, Pedro (Ed.) Le patient, la famille, l'équipe thérapeutique de l'Hôpital de jour (1994)

Detailed reference viewed: 7 (2 ULg)
Full Text
Peer Reviewed
See detailPatient-specific modelling of cardiovascular dysfunction: Identifying models of pulmonary embolism in pigs
Desaive, Thomas ULg; Revie, J; Hann, CE et al

in Proceedings of the 19th International Conference of the Cardiovascular System Dynamics Society (2010)

Detailed reference viewed: 6 (0 ULg)